RNA-mediated gene silencing in non-pathogenic and pathogenic fungi.

PubWeight™: 0.90‹?›

🔗 View Article (PMID 12057689)

Published in Curr Opin Microbiol on June 01, 2002

Authors

Marianne D De Backer1, Mitch Raponi, Greg M Arndt

Author Affiliations

1: Johnson and Johnson Pharmaceutical Research and Development, Department GI Emerging Diseases, Turnhoutseweg 30, B-2340, Beerse, Belgium. mdbacker@janbe.jnj.com

Articles by these authors

Rociletinib in EGFR-mutated non-small-cell lung cancer. N Engl J Med (2015) 6.28

Discovery of a mutant-selective covalent inhibitor of EGFR that overcomes T790M-mediated resistance in NSCLC. Cancer Discov (2013) 2.93

Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer. BMC Cancer (2009) 2.27

Multi-institutional phase 2 clinical and pharmacogenomic trial of tipifarnib plus etoposide for elderly adults with newly diagnosed acute myelogenous leukemia. Blood (2011) 1.56

Genome-wide screening for gene function using RNAi in mammalian cells. Immunol Cell Biol (2005) 1.41

Extracellular matrix metalloproteinase inducer (CD147) confers resistance of breast cancer cells to Anoikis through inhibition of Bim. J Biol Chem (2006) 1.41

Randomized, multicenter, phase II study of CO-101 versus gemcitabine in patients with metastatic pancreatic ductal adenocarcinoma: including a prospective evaluation of the role of hENT1 in gemcitabine or CO-101 sensitivity. J Clin Oncol (2013) 1.30

Detection and characterization of OX40 ligand expression in human airway smooth muscle cells: a possible role in asthma? J Allergy Clin Immunol (2004) 1.16

Long-term survival and concomitant gene expression of ribozyme-transduced CD4+ T-lymphocytes in HIV-infected patients. J Gene Med (2005) 1.11

Expressing functional siRNAs in mammalian cells using convergent transcription. BMC Biotechnol (2003) 1.11

Sequence determinants of innate immune activation by short interfering RNAs. BMC Immunol (2009) 0.98

Double-stranded RNA-mediated gene silencing in fission yeast. Nucleic Acids Res (2003) 0.95

Dominant genetic screen for cofactors that enhance antisense RNA-mediated gene silencing in fission yeast. Nucleic Acids Res (2002) 0.90

Phase II trial and prediction of response of single agent tipifarnib in patients with relapsed/refractory mantle cell lymphoma: a Groupe d'Etude des Lymphomes de l'Adulte trial. Cancer Chemother Pharmacol (2009) 0.84

Control of specific gene expression in mammalian cells by co-expression of long complementary RNAs. FEBS Lett (2004) 0.83

Competition between siRNA duplexes: impact of RNA-induced silencing complex loading efficiency and comparison between conventional-21 bp and Dicer-substrate siRNAs. Oligonucleotides (2010) 0.82

Interfering ribonucleic acids that suppress expression of multiple unrelated genes. BMC Biotechnol (2009) 0.79

RNA modulators of complex phenotypes in mammalian cells. PLoS One (2009) 0.78

Circulating tumor cells: utility for predicting response to anti-EGFR therapies? Expert Rev Mol Diagn (2009) 0.75